Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit
Top Cited Papers
Open Access
- 16 June 2020
- journal article
- letter
- Published by American Medical Association (AMA) in Jama-Journal Of The American Medical Association
- Vol. 323 (23), 2424-2425
- https://doi.org/10.1001/jama.2020.8438
Abstract
Dialysis units are at especially high risk of infectious disease transmission, and concern exists about spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Dialysis units in Wuhan, China, have reported high coronavirus disease 2019 (COVID-19) prevalence, due in part to unique exposure challenges that limit social distancing efforts, including open bay formats and rotating/multiple nursing assignments.1,2 This study describes SARS-CoV-2 seroconversion in patients and health care workers in a pediatric dialysis unit.This publication has 4 references indexed in Scilit:
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)Clinical Infectious Diseases, 2020
- How we mitigated and contained the COVID-19 outbreak in a hemodialysis center: Lessons and experienceInfection Control & Hospital Epidemiology, 2020
- SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test SetupCurrent Protocols in Microbiology, 2020
- Mitigating Risk of COVID-19 in Dialysis FacilitiesClinical Journal of the American Society of Nephrology, 2020